Neuralink seeks to enroll three patients in a years-long study of its brain implant device for paralyzed individuals.
Neuralink, Elon Musk's brain-chip company, plans to enroll three patients for a study evaluating its brain implant device, with completion expected to take several years. The company initially sought to enroll 10 patients when it applied to U.S. regulators to begin clinical trials. Neuralink is testing its implant designed to help paralyzed patients use digital devices by thinking alone, assisting those with spinal cord injuries.
May 28, 2024
27 Articles